Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Funds / Concr Jun 2023 a Series of Cgf2021 LLC

Concr Jun 2023 a Series of Cgf2021 LLC

Active deploymentClosed to new capitalSPV or co-invest vehicleADV: Venture Capital FundOncology Ventures LLCDelaware
Amounts, each with its basis
Vintage
2023basis: form d first sale
Target
unknownnot announced
First close
unknownnever inferred from a Form D
Final close
unknownonly from an announcement or an LP disclosure
Announced size
unknown
Form D offering
$410,990what may be sold, not what was raised; file 021-495890, sworn by the adviser or filed under this vehicle
Form D sold
$410,990as of the filing of Oct 30, 2023, 17 investors
First sale
Oct 20, 2023
Reported GAV
$410,990on the Form ADV filed Sep 12, 2026; the fund's assets, never its size or dry powder
Owners (ADV)
18
Reported on ADV
Sep 12, 2026 to Sep 12, 2026
Fundraising evidence
Closed to new capital
Form D filed or amended 2023-10-30: the stated $410,990 offering reported fully sold (fr-1)
evidence dated Oct 30, 2023. A Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.
Lifecycle
Active deployment
vintage 2 to 4 years
age years: 3first sale: 2023-10-20vintage year: $2,023adv gav as of: 2026-09-12vintage basis: form_d_first_saleform d sold usd: $410,990form d offering usd: $410,990form d latest filed at: 2023-10-30
The fund's own reporting through time
1 Form ADV filings
FiledTypeGross asset value OwnersMin. investmentAdviser-ownedAudit
Sep 12, 2026Venture Capital Fund$410,990
180%
Principals and agents
3 principals on Form D, 0 placement agents
  • Taylor Hughes Executive Officer
  • LLC Sydecar Director
  • LLC Sydecar general partner (ADV 7.B.(1).A.3)
Limited partners and their reported performance
0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
2 events
  1. Sep 12, 2026
    Concr Jun 2023 a Series of Cgf2021 LLC first reported on Form ADV by Oncology Ventures LLC, GAV $410,990
    Fund first reported on Form ADV Fact IAPD Form ADV Part 1 PDF per firm (current filing, Schedule D 7.B.(1) and Schedule A)
  2. Oct 30, 2023
    Concr Jun 2023 a Series of CGF2021 LLC filed Form D: $410,990 sold of $410,990, Venture Capital Fund
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
17 observations
Every observation on this vehicle